speb/financial-data huggingface dataset:
SPSY.L cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 916679.00
SPSY.L income_statement (annual, 2022-12-31) — Diluted Average Shares: 47321818.00
SPSY.L income_statement (annual, 2022-12-31) — Diluted EPS: 0.13
SPSY.L income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 6147374.00
SPSY.L income_statement (annual, 2022-12-31) — EBIT: 6992940.00
SPSY.L income_statement (annual, 2022-12-31) — EBITDA: 7909619.00
SPSY.L cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -50446.00
SPSY.L cash_flow (annual, 2022-12-31) — End Cash Position: 17495830.00
SPSY.L cash_flow (annual, 2022-12-31) — Financing Cash Flow: -5805835.00
SPSY.L balance_sheet (annual, 2022-12-31) — Finished Goods: 1294811.00
SPSY.L cash_flow (annual, 2022-12-31) — Free Cash Flow: 6577015.00
SPSY.L income_statement (annual, 2022-12-31) — General And Administrative Expense: 3023263.00
SPSY.L balance_sheet (annual, 2022-12-31) — Goodwill: 3040607.00
SPSY.L balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 7134491.00
SPSY.L balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 3676782.00
SPSY.L balance_sheet (annual, 2022-12-31) — Gross PPE: 7294309.00
SPSY.L income_statement (annual, 2022-12-31) — Gross Profit: 12276211.00
SPSY.L income_statement (annual, 2022-12-31) — Interest Income: 17591.00
SPSY.L income_statement (annual, 2022-12-31) — Interest Income Non Operating: 17591.00
SPSY.L balance_sheet (annual, 2022-12-31) — Inventories Adjustments Allowances: -1444000.00
SPSY.L balance_sheet (annual, 2022-12-31) — Inventory: 1598732.00
SPSY.L balance_sheet (annual, 2022-12-31) — Invested Capital: 27726687.00
SPSY.L cash_flow (annual, 2022-12-31) — Investing Cash Flow: -1464511.00
SPSY.L cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 5926.00
SPSY.L cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
SPSY.L balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 974868.00
SPSY.L balance_sheet (annual, 2022-12-31) — Long Term Debt: 0.00
SPSY.L balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 974868.00
SPSY.L balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 3023262.00
SPSY.L balance_sheet (annual, 2022-12-31) — Minority Interest: 595986.00
SPSY.L income_statement (annual, 2022-12-31) — Minority Interests: 46236.00
SPSY.L cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
SPSY.L cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -801421.00
SPSY.L income_statement (annual, 2022-12-31) — Net Income: 6147374.00
SPSY.L income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 6147374.00
SPSY.L income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 6101138.00
SPSY.L income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 6147374.00
SPSY.L income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 6147374.00
SPSY.L cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 6101138.00
SPSY.L income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 6101138.00
SPSY.L cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -476346.00
SPSY.L income_statement (annual, 2022-12-31) — Net Interest Income: 17591.00
SPSY.L cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 0.00
SPSY.L income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 17591.00
SPSY.L balance_sheet (annual, 2022-12-31) — Net PPE: 3219229.00
SPSY.L cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -988165.00
SPSY.L cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 0.00
SPSY.L balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 20592196.00
SPSY.L balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 1679257.00
SPSY.L balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 1881000.00
SPSY.L balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 518611.00
SPSY.L income_statement (annual, 2022-12-31) — Normalized EBITDA: 7909619.00
SPSY.L income_statement (annual, 2022-12-31) — Normalized Income: 6147374.00
SPSY.L cash_flow (annual, 2022-12-31) — Operating Cash Flow: 8041526.00
SPSY.L income_statement (annual, 2022-12-31) — Operating Income: 6992940.00
SPSY.L income_statement (annual, 2022-12-31) — Operating Revenue: 19626737.00
SPSY.L balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 45011001.00
SPSY.L balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 41485.00
SPSY.L balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 4093884.00
SPSY.L cash_flow (annual, 2022-12-31) — Other Non Cash Items: 287062.00
SPSY.L balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 100000.00
SPSY.L balance_sheet (annual, 2022-12-31) — Other Properties: 2708861.00
SPSY.L balance_sheet (annual, 2022-12-31) — Other Receivables: 1132664.00
SPSY.L income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
SPSY.L balance_sheet (annual, 2022-12-31) — Payables: 1622528.00
SPSY.L balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 289727.00
SPSY.L balance_sheet (annual, 2022-12-31) — Prepaid Assets: 759926.00
SPSY.L income_statement (annual, 2022-12-31) — Pretax Income: 7002538.00
SPSY.L balance_sheet (annual, 2022-12-31) — Properties: 0.00
SPSY.L cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 690435.00
SPSY.L cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
SPSY.L cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -476346.00
SPSY.L cash_flow (annual, 2022-12-31) — Purchase Of PPE: -988165.00
SPSY.L balance_sheet (annual, 2022-12-31) — Raw Materials: 1642046.00
SPSY.L income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 7350526.00
SPSY.L income_statement (annual, 2022-12-31) — Reconciled Depreciation: 916679.00
SPSY.L cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -807347.00
SPSY.L income_statement (annual, 2022-12-31) — Research And Development: 1507034.00
SPSY.L balance_sheet (annual, 2022-12-31) — Retained Earnings: -25727077.00
SPSY.L cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
SPSY.L income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 752974.00
SPSY.L income_statement (annual, 2022-12-31) — Selling General And Administration: 3776237.00
SPSY.L balance_sheet (annual, 2022-12-31) — Share Issued: 45011001.00
SPSY.L cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 0.00
SPSY.L income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
SPSY.L cash_flow (annual, 2022-12-31) — Stock Based Compensation: 142981.00
SPSY.L balance_sheet (annual, 2022-12-31) — Stockholders Equity: 27726687.00
SPSY.L balance_sheet (annual, 2022-12-31) — Tangible Book Value: 20592196.00
SPSY.L income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
SPSY.L income_statement (annual, 2022-12-31) — Tax Provision: 901400.00
SPSY.L income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.13
SPSY.L balance_sheet (annual, 2022-12-31) — Total Assets: 38017265.00
SPSY.L balance_sheet (annual, 2022-12-31) — Total Capitalization: 27726687.00
SPSY.L balance_sheet (annual, 2022-12-31) — Total Debt: 1273110.00
SPSY.L balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 28322673.00
SPSY.L income_statement (annual, 2022-12-31) — Total Expenses: 12633797.00
SPSY.L balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 9694592.00
SPSY.L balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 13353331.00
SPSY.L balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 2654125.00
SPSY.L income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 6992940.00
SPSY.L balance_sheet (annual, 2022-12-31) — Total Tax Payable: 693698.00
SPSY.L income_statement (annual, 2022-12-31) — Total Unusual Items: 0.00
SPSY.L income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 0.00
SPSY.L balance_sheet (annual, 2022-12-31) — Work In Process: 105875.00
SPSY.L balance_sheet (annual, 2022-12-31) — Working Capital: 17623467.00
SPSY.L income_statement (annual, 2023-12-31) — +Operating Expense: 6472502.00
SPSY.L income_statement (annual, 2023-12-31) — +Total Revenue: 20288201.00
SPSY.L balance_sheet (annual, 2023-12-31) — Accounts Payable: 2752989.00
SPSY.L balance_sheet (annual, 2023-12-31) — Accounts Receivable: 3777129.00
SPSY.L balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -4491574.00
SPSY.L balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 56152570.00
SPSY.L balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -127228.00
SPSY.L income_statement (annual, 2023-12-31) — Basic Average Shares: 45074264.00
SPSY.L income_statement (annual, 2023-12-31) — Basic EPS: 0.13
SPSY.L cash_flow (annual, 2023-12-31) — Beginning Cash Position: 17495830.00
SPSY.L balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 1814032.00
SPSY.L cash_flow (annual, 2023-12-31) — Capital Expenditure: -482424.00
SPSY.L balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 6382226.00
SPSY.L balance_sheet (annual, 2023-12-31) — Capital Stock: 460066.00
SPSY.L balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 13253219.00
SPSY.L balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 13253219.00
SPSY.L cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -5181799.00
SPSY.L cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -189740.00
SPSY.L cash_flow (annual, 2023-12-31) — Change In Inventory: -1469814.00
SPSY.L cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 1250073.00
SPSY.L cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -177026.00
SPSY.L cash_flow (annual, 2023-12-31) — Change In Payable: -345389.00
SPSY.L cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -449251.00
SPSY.L cash_flow (annual, 2023-12-31) — Change In Receivables: 2337130.00
SPSY.L cash_flow (annual, 2023-12-31) — Change In Working Capital: 1133009.00
SPSY.L cash_flow (annual, 2023-12-31) — Changes In Cash: -4250211.00
SPSY.L balance_sheet (annual, 2023-12-31) — Common Stock: 460066.00
SPSY.L balance_sheet (annual, 2023-12-31) — Common Stock Equity: 31540850.00
SPSY.L cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
SPSY.L cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
SPSY.L income_statement (annual, 2023-12-31) — Cost Of Revenue: 6664330.00
SPSY.L balance_sheet (annual, 2023-12-31) — Current Assets: 26138824.00
SPSY.L balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 1107206.00
SPSY.L balance_sheet (annual, 2023-12-31) — Current Debt: 2015526.00
SPSY.L balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 3122732.00
SPSY.L balance_sheet (annual, 2023-12-31) — Current Liabilities: 13259865.00
SPSY.L cash_flow (annual, 2023-12-31) — Deferred Tax: -886281.00
SPSY.L cash_flow (annual, 2023-12-31) — Depreciation: 1054959.00
SPSY.L cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 1054959.00
SPSY.L income_statement (annual, 2023-12-31) — Diluted Average Shares: 48761954.00
SPSY.L income_statement (annual, 2023-12-31) — Diluted EPS: 0.12
SPSY.L income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 6047921.00
SPSY.L income_statement (annual, 2023-12-31) — EBIT: 7463392.00
SPSY.L income_statement (annual, 2023-12-31) — EBITDA: 8518351.00
SPSY.L cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 7600.00
SPSY.L cash_flow (annual, 2023-12-31) — End Cash Position: 13253219.00
SPSY.L cash_flow (annual, 2023-12-31) — Financing Cash Flow: -5100063.00
SPSY.L balance_sheet (annual, 2023-12-31) — Finished Goods: 1477065.00
SPSY.L cash_flow (annual, 2023-12-31) — Free Cash Flow: 7041519.00
SPSY.L income_statement (annual, 2023-12-31) — General And Administrative Expense: 4197974.00
SPSY.L balance_sheet (annual, 2023-12-31) — Goodwill: 6597897.00
SPSY.L balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 13579961.00
SPSY.L balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 3904357.00
SPSY.L balance_sheet (annual, 2023-12-31) — Gross PPE: 21898305.00
SPSY.L income_statement (annual, 2023-12-31) — Gross Profit: 13623871.00
SPSY.L income_statement (annual, 2023-12-31) — Interest Expense: 9125.00
SPSY.L income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 9125.00
SPSY.L income_statement (annual, 2023-12-31) — Interest Income: 385014.00
SPSY.L income_statement (annual, 2023-12-31) — Interest Income Non Operating: 385014.00
SPSY.L balance_sheet (annual, 2023-12-31) — Inventories Adjustments Allowances: -1682955.00
SPSY.L balance_sheet (annual, 2023-12-31) — Inventory: 6507042.00
SPSY.L balance_sheet (annual, 2023-12-31) — Invested Capital: 37685470.00
SPSY.L cash_flow (annual, 2023-12-31) — Investing Cash Flow: -6674091.00
SPSY.L cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
SPSY.L cash_flow (annual, 2023-12-31) — Issuance Of Debt: 112501.00
SPSY.L balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 5275020.00
SPSY.L balance_sheet (annual, 2023-12-31) — Long Term Debt: 4129094.00
SPSY.L balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 9404114.00
SPSY.L cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -30765.00
SPSY.L balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 12259889.00
SPSY.L balance_sheet (annual, 2023-12-31) — Minority Interest: 572613.00
SPSY.L income_statement (annual, 2023-12-31) — Minority Interests: 23373.00
SPSY.L cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -6200986.00
SPSY.L cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
SPSY.L income_statement (annual, 2023-12-31) — Net Income: 6047921.00
SPSY.L income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 6047921.00
SPSY.L income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 6024548.00
SPSY.L income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 6047921.00
SPSY.L income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 6047921.00
SPSY.L cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 6024548.00
SPSY.L income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 6024548.00
SPSY.L cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -331616.00
SPSY.L income_statement (annual, 2023-12-31) — Net Interest Income: 375889.00
SPSY.L cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 81736.00
SPSY.L cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -30765.00
SPSY.L income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 375889.00
SPSY.L cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -30765.00
SPSY.L balance_sheet (annual, 2023-12-31) — Net PPE: 17406731.00
SPSY.L cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -141489.00
SPSY.L cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 112501.00
SPSY.L balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 17960889.00
SPSY.L balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 1499927.00
SPSY.L balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 1844042.00
SPSY.L balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 518799.00
SPSY.L income_statement (annual, 2023-12-31) — Normalized EBITDA: 8518351.00
SPSY.L income_statement (annual, 2023-12-31) — Normalized Income: 6047921.00
SPSY.L cash_flow (annual, 2023-12-31) — Operating Cash Flow: 7523943.00
SPSY.L income_statement (annual, 2023-12-31) — Operating Income: 7151369.00
SPSY.L income_statement (annual, 2023-12-31) — Operating Revenue: 20288201.00
SPSY.L balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 46006608.00
SPSY.L balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 40773.00
SPSY.L balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 6982064.00
SPSY.L cash_flow (annual, 2023-12-31) — Other Non Cash Items: 17484.00
SPSY.L balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 3819090.00
SPSY.L balance_sheet (annual, 2023-12-31) — Other Properties: 7824384.00
SPSY.L balance_sheet (annual, 2023-12-31) — Other Receivables: 1394480.00
SPSY.L income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
SPSY.L balance_sheet (annual, 2023-12-31) — Payables: 3276276.00
SPSY.L balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 384594.00
SPSY.L balance_sheet (annual, 2023-12-31) — Prepaid Assets: 1206954.00
SPSY.L income_statement (annual, 2023-12-31) — Pretax Income: 7454267.00
SPSY.L balance_sheet (annual, 2023-12-31) — Properties: 0.00
SPSY.L cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 366184.00
SPSY.L cash_flow (annual, 2023-12-31) — Purchase Of Business: -6200986.00
SPSY.L cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -331616.00
SPSY.L cash_flow (annual, 2023-12-31) — Purchase Of PPE: -150808.00
SPSY.L balance_sheet (annual, 2023-12-31) — Raw Materials: 5540541.00
SPSY.L income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 6664330.00
SPSY.L income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1054959.00
SPSY.L cash_flow (annual, 2023-12-31) — Repayment Of Debt: -30765.00
SPSY.L cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: 0.00
SPSY.L income_statement (annual, 2023-12-31) — Research And Development: 1450197.00
SPSY.L balance_sheet (annual, 2023-12-31) — Retained Earnings: -24860954.00
SPSY.L cash_flow (annual, 2023-12-31) — Sale Of PPE: 9319.00
SPSY.L income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 824331.00
SPSY.L income_statement (annual, 2023-12-31) — Selling General And Administration: 5022305.00
SPSY.L balance_sheet (annual, 2023-12-31) — Share Issued: 46006608.00
SPSY.L cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 112501.00
SPSY.L cash_flow (annual, 2023-12-31) — Stock Based Compensation: 180224.00
SPSY.L balance_sheet (annual, 2023-12-31) — Stockholders Equity: 31540850.00
SPSY.L balance_sheet (annual, 2023-12-31) — Tangible Book Value: 17960889.00
SPSY.L income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
SPSY.L income_statement (annual, 2023-12-31) — Tax Provision: 1429719.00
SPSY.L income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.19
SPSY.L balance_sheet (annual, 2023-12-31) — Total Assets: 60096459.00
SPSY.L balance_sheet (annual, 2023-12-31) — Total Capitalization: 35669944.00
SPSY.L balance_sheet (annual, 2023-12-31) — Total Debt: 12526846.00
SPSY.L balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 32113463.00
SPSY.L income_statement (annual, 2023-12-31) — Total Expenses: 13136832.00
SPSY.L balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 27982996.00
SPSY.L balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 33957635.00
SPSY.L balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 14723131.00
SPSY.L income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 7151369.00
SPSY.L balance_sheet (annual, 2023-12-31) — Total Tax Payable: 523287.00
SPSY.L balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
SPSY.L balance_sheet (annual, 2023-12-31) — Work In Process: 1172391.00
SPSY.L balance_sheet (annual, 2023-12-31) — Working Capital: 12878959.00
SPSY.L income_statement (annual, 2024-12-31) — +Operating Expense: 12010268.00
SPSY.L income_statement (annual, 2024-12-31) — +Total Revenue: 49191335.00
SPSY.L balance_sheet (annual, 2024-12-31) — Accounts Payable: 3630760.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 3630760.00
SPSY.L balance_sheet (annual, 2024-12-31) — Accounts Receivable: 2999906.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 2999906.00
SPSY.L balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -5652993.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -5652993.00
SPSY.L balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 57604889.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 57604889.00
SPSY.L balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -4934.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -4934.00
SPSY.L income_statement (annual, 2024-12-31) — Basic Average Shares: 48023360.00
SPSY.L income_statement (annual, 2024-12-31) — Basic EPS: 0.18
SPSY.L cash_flow (annual, 2024-12-31) — Beginning Cash Position: 13253219.00
SPSY.L balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 1972294.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 1972294.00
SPSY.L cash_flow (annual, 2024-12-31) — Capital Expenditure: -1434229.00
SPSY.L balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 5767229.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 5767229.00
SPSY.L balance_sheet (annual, 2024-12-31) — Capital Stock: 482409.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Capital Stock: 482409.00
SPSY.L balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 13354435.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 13354435.00
SPSY.L balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 13354435.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 13354435.00
SPSY.L cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -5594562.00
SPSY.L cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 1140333.00
SPSY.L cash_flow (annual, 2024-12-31) — Change In Inventory: 258412.00
SPSY.L cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -2079315.00
SPSY.L cash_flow (annual, 2024-12-31) — Change In Payable: 911906.00
SPSY.L cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 445475.00
SPSY.L cash_flow (annual, 2024-12-31) — Change In Receivables: -2448079.00
SPSY.L cash_flow (annual, 2024-12-31) — Change In Working Capital: -1771268.00
SPSY.L cash_flow (annual, 2024-12-31) — Changes In Cash: 52000.00
SPSY.L balance_sheet (annual, 2024-12-31) — Common Stock: 482409.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Common Stock: 482409.00
SPSY.L balance_sheet (annual, 2024-12-31) — Common Stock Equity: 35773597.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 35773597.00
SPSY.L cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
SPSY.L income_statement (annual, 2024-12-31) — Cost Of Revenue: 25702081.00
SPSY.L balance_sheet (annual, 2024-12-31) — Current Assets: 28309528.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Current Assets: 28309528.00
SPSY.L balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 798258.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 798258.00
SPSY.L balance_sheet (annual, 2024-12-31) — Current Debt: 2164969.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Current Debt: 2164969.00
SPSY.L balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 2963227.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 2963227.00
SPSY.L balance_sheet (annual, 2024-12-31) — Current Liabilities: 14018138.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 14018138.00
SPSY.L balance_sheet (annual, 2024-12-31) — Current Provisions: 31389.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Current Provisions: 31389.00
SPSY.L cash_flow (annual, 2024-12-31) — Deferred Tax: -227850.00
SPSY.L cash_flow (annual, 2024-12-31) — Depreciation: 3193747.00
SPSY.L cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 3193747.00
SPSY.L income_statement (annual, 2024-12-31) — Diluted Average Shares: 48958589.00
SPSY.L income_statement (annual, 2024-12-31) — Diluted EPS: 0.17
SPSY.L income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 8520045.00
SPSY.L income_statement (annual, 2024-12-31) — EBIT: 11502426.00
SPSY.L income_statement (annual, 2024-12-31) — EBITDA: 14696173.00
SPSY.L cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 49216.00
SPSY.L cash_flow (annual, 2024-12-31) — End Cash Position: 13354435.00
SPSY.L cash_flow (annual, 2024-12-31) — Financing Cash Flow: -6862190.00
SPSY.L balance_sheet (annual, 2024-12-31) — Finished Goods: 1513649.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Finished Goods: 1513649.00
SPSY.L cash_flow (annual, 2024-12-31) — Free Cash Flow: 8464530.00
SPSY.L income_statement (annual, 2024-12-31) — General And Administrative Expense: 8391884.00
SPSY.L balance_sheet (annual, 2024-12-31) — Goodwill: 6597897.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Goodwill: 6597897.00
SPSY.L balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 13564467.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 13564467.00
SPSY.L balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 3004840.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 3004840.00
SPSY.L balance_sheet (annual, 2024-12-31) — Gross PPE: 20385243.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Gross PPE: 20385243.00
SPSY.L income_statement (annual, 2024-12-31) — Gross Profit: 23489254.00
SPSY.L income_statement (annual, 2024-12-31) — Interest Expense: 197875.00
SPSY.L income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 197875.00
SPSY.L income_statement (annual, 2024-12-31) — Interest Income: 150059.00
SPSY.L income_statement (annual, 2024-12-31) — Interest Income Non Operating: 150059.00
SPSY.L balance_sheet (annual, 2024-12-31) — Inventories Adjustments Allowances: -1234000.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Inventories Adjustments Allowances: -1234000.00
SPSY.L balance_sheet (annual, 2024-12-31) — Inventory: 6206049.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Inventory: 6206049.00
SPSY.L balance_sheet (annual, 2024-12-31) — Invested Capital: 40585062.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Invested Capital: 40585062.00
SPSY.L cash_flow (annual, 2024-12-31) — Investing Cash Flow: -2984569.00
SPSY.L balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 4968971.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 4968971.00
SPSY.L balance_sheet (annual, 2024-12-31) — Long Term Debt: 2646496.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 2646496.00
SPSY.L balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 7615467.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 7615467.00
SPSY.L cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -1128369.00
SPSY.L balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 11183758.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 11183758.00
SPSY.L balance_sheet (annual, 2024-12-31) — Minority Interest: 554718.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Minority Interest: 554718.00
SPSY.L income_statement (annual, 2024-12-31) — Minority Interests: 17895.00
SPSY.L cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
SPSY.L cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
SPSY.L income_statement (annual, 2024-12-31) — Net Income: 8520045.00
SPSY.L income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 8520045.00
SPSY.L income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 8502151.00
SPSY.L income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 8520045.00
SPSY.L income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 8520045.00
SPSY.L cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 8502150.00
SPSY.L income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 8502150.00
SPSY.L cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -688973.00
SPSY.L income_statement (annual, 2024-12-31) — Net Interest Income: -47816.00
SPSY.L cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -1267628.00
SPSY.L cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -1128369.00
SPSY.L income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -47816.00
SPSY.L cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -1550340.00
SPSY.L balance_sheet (annual, 2024-12-31) — Net PPE: 14732250.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Net PPE: 14732250.00
SPSY.L cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -745256.00
SPSY.L cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: -139259.00
SPSY.L balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 22209130.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 22209130.00
SPSY.L balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 499449.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Revenue: 499449.00
SPSY.L balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 2092774.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Assets: 2092774.00
SPSY.L balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 118170.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Non Current Prepaid Assets: 118170.00
SPSY.L income_statement (annual, 2024-12-31) — Normalized EBITDA: 14696173.00
SPSY.L income_statement (annual, 2024-12-31) — Normalized Income: 8520045.00
SPSY.L cash_flow (annual, 2024-12-31) — Operating Cash Flow: 9898759.00
SPSY.L income_statement (annual, 2024-12-31) — Operating Income: 11478986.00
SPSY.L income_statement (annual, 2024-12-31) — Operating Revenue: 49191335.00
SPSY.L balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 48240972.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 48240972.00
SPSY.L balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 302781.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 302781.00
SPSY.L balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 6966570.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 6966570.00
SPSY.L cash_flow (annual, 2024-12-31) — Other Non Cash Items: 10094.00
SPSY.L balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 2513020.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: 2513020.00
SPSY.L balance_sheet (annual, 2024-12-31) — Other Properties: 7229191.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Other Properties: 7229191.00
SPSY.L balance_sheet (annual, 2024-12-31) — Other Receivables: 4597340.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Other Receivables: 4597340.00
SPSY.L income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
SPSY.L balance_sheet (annual, 2024-12-31) — Payables: 5053168.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Payables: 5053168.00
SPSY.L balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 500389.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 500389.00
SPSY.L balance_sheet (annual, 2024-12-31) — Prepaid Assets: 1151798.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 1151798.00
SPSY.L income_statement (annual, 2024-12-31) — Pretax Income: 11304551.00
SPSY.L balance_sheet (annual, 2024-12-31) — Properties: 0.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
SPSY.L cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
SPSY.L cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -688973.00
SPSY.L cash_flow (annual, 2024-12-31) — Purchase Of PPE: -745256.00
SPSY.L balance_sheet (annual, 2024-12-31) — Raw Materials: 4532396.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Raw Materials: 4532396.00
SPSY.L income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 25702081.00
SPSY.L income_statement (annual, 2024-12-31) — Reconciled Depreciation: 3193747.00
SPSY.L cash_flow (annual, 2024-12-31) — Repayment Of Debt: -1128369.00
SPSY.L cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
SPSY.L income_statement (annual, 2024-12-31) — Research And Development: 2161550.00
SPSY.L income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
SPSY.L balance_sheet (annual, 2024-12-31) — Retained Earnings: -21935471.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -21935471.00
SPSY.L cash_flow (annual, 2024-12-31) — Sale Of PPE: 0.00
SPSY.L income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 1456834.00
SPSY.L income_statement (annual, 2024-12-31) — Selling General And Administration: 9848718.00
SPSY.L balance_sheet (annual, 2024-12-31) — Share Issued: 48240972.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Share Issued: 48240972.00
SPSY.L income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
SPSY.L cash_flow (annual, 2024-12-31) — Stock Based Compensation: 191886.00
SPSY.L balance_sheet (annual, 2024-12-31) — Stockholders Equity: 35773597.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 35773597.00
SPSY.L balance_sheet (annual, 2024-12-31) — Tangible Book Value: 22209130.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 22209130.00
SPSY.L income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
SPSY.L income_statement (annual, 2024-12-31) — Tax Provision: 2802400.00
SPSY.L income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.25
SPSY.L balance_sheet (annual, 2024-12-31) — Total Assets: 60974389.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Total Assets: 60974389.00
SPSY.L balance_sheet (annual, 2024-12-31) — Total Capitalization: 38420093.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 38420093.00
SPSY.L balance_sheet (annual, 2024-12-31) — Total Debt: 10578694.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Total Debt: 10578694.00
SPSY.L balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 36328315.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 36328315.00
SPSY.L income_statement (annual, 2024-12-31) — Total Expenses: 37712349.00
SPSY.L balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 24646074.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 24646074.00
SPSY.L balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 32664861.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 32664861.00
SPSY.L balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 10627936.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 10627936.00
SPSY.L income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 11478986.00
SPSY.L balance_sheet (annual, 2024-12-31) — Total Tax Payable: 1422408.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 1422408.00
SPSY.L income_statement (annual, 2024-12-31) — Total Unusual Items: 0.00
SPSY.L income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
SPSY.L balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 0.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 0.00
SPSY.L balance_sheet (annual, 2024-12-31) — Treasury Stock: 0.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 0.00
SPSY.L balance_sheet (annual, 2024-12-31) — Work In Process: 1394004.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Work In Process: 1394004.00
SPSY.L balance_sheet (annual, 2024-12-31) — Working Capital: 14291390.00
SPSY.L balance_sheet (quarterly, 2024-12-31) — Working Capital: 14291390.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 4993000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 2558000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 57654000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 5671000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Capital Stock: 482000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 2556000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 2556000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Common Stock: 482000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 40955000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Current Assets: 29525000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 330000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Current Debt: 3112000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 3442000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 13028000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 13797000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Gross PPE: 14730000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Inventory: 9153000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Invested Capital: 45919000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 5341000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 1852000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 7193000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Minority Interest: 550000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Net Debt: 2408000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Net PPE: 14730000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 27158000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 0.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 1020000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 48300689.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 65000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 2513000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Other Properties: 14730000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Other Receivables: 14431000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Payables: 6585000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 827000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -17473000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Share Issued: 48300689.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 40955000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 27158000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Total Assets: 64239000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 42807000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Total Debt: 10635000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 41505000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 22734000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 34714000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 9706000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 1592000.00
SPSY.L balance_sheet (quarterly, 2025-06-30) — Working Capital: 16497000.00
SPSY.L income_statement (annual, 2025-12-31) — +Operating Expense: 12769517.00
SPSY.L income_statement (annual, 2025-12-31) — +Total Revenue: 64283895.00
SPSY.L balance_sheet (annual, 2025-12-31) — Accounts Payable: 4246745.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 4246745.00
SPSY.L balance_sheet (annual, 2025-12-31) — Accounts Receivable: 2906298.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 2906298.00
SPSY.L balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -9823200.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -9823200.00
SPSY.L balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 57702006.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 57702006.00
SPSY.L balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
SPSY.L cash_flow (annual, 2025-12-31) — Beginning Cash Position: 13354435.00
SPSY.L balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 1984770.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 1984770.00
SPSY.L cash_flow (annual, 2025-12-31) — Capital Expenditure: -494688.00
SPSY.L balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 5130828.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 5130828.00
SPSY.L balance_sheet (annual, 2025-12-31) — Capital Stock: 483006.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Capital Stock: 483006.00
SPSY.L balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 14819957.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 14819957.00
SPSY.L balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 14819957.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 14819957.00
SPSY.L cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -5611529.00
SPSY.L cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 2056273.00
SPSY.L cash_flow (annual, 2025-12-31) — Change In Inventory: -1594565.00
SPSY.L cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -2198767.00
SPSY.L cash_flow (annual, 2025-12-31) — Change In Payable: 310775.00
SPSY.L cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 405772.00
SPSY.L cash_flow (annual, 2025-12-31) — Change In Receivables: -9956847.00
SPSY.L cash_flow (annual, 2025-12-31) — Change In Working Capital: -10977359.00
SPSY.L cash_flow (annual, 2025-12-31) — Changes In Cash: 1434403.00
SPSY.L balance_sheet (annual, 2025-12-31) — Common Stock: 483006.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Common Stock: 483006.00
SPSY.L balance_sheet (annual, 2025-12-31) — Common Stock Equity: 50814354.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 50814354.00
SPSY.L cash_flow (annual, 2025-12-31) — Common Stock Payments: -36000.00
SPSY.L income_statement (annual, 2025-12-31) — Cost Of Revenue: 27211956.00
SPSY.L balance_sheet (annual, 2025-12-31) — Current Assets: 41431307.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Current Assets: 41431307.00
SPSY.L balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 647124.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 647124.00
SPSY.L balance_sheet (annual, 2025-12-31) — Current Debt: 2414257.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Current Debt: 2414257.00
SPSY.L balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 3061381.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 3061381.00
SPSY.L balance_sheet (annual, 2025-12-31) — Current Liabilities: 14733282.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 14733282.00
SPSY.L balance_sheet (annual, 2025-12-31) — Current Provisions: 1828.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Current Provisions: 1828.00
SPSY.L cash_flow (annual, 2025-12-31) — Deferred Tax: 468005.00
SPSY.L cash_flow (annual, 2025-12-31) — Depreciation: 2902998.00
SPSY.L cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 2902998.00
SPSY.L income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 20055897.00
SPSY.L income_statement (annual, 2025-12-31) — EBIT: 26980442.00
SPSY.L income_statement (annual, 2025-12-31) — EBITDA: 29883440.00
SPSY.L cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 31119.00
SPSY.L cash_flow (annual, 2025-12-31) — End Cash Position: 14819957.00
SPSY.L cash_flow (annual, 2025-12-31) — Financing Cash Flow: -7061412.00
SPSY.L balance_sheet (annual, 2025-12-31) — Finished Goods: 2711951.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Finished Goods: 2711951.00
SPSY.L cash_flow (annual, 2025-12-31) — Free Cash Flow: 9612689.00
SPSY.L income_statement (annual, 2025-12-31) — General And Administrative Expense: 8984247.00
SPSY.L balance_sheet (annual, 2025-12-31) — Goodwill: 6597897.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Goodwill: 6597897.00
SPSY.L balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 13079207.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 13079207.00
SPSY.L balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 2906298.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 2906298.00
SPSY.L balance_sheet (annual, 2025-12-31) — Gross PPE: 23001039.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Gross PPE: 23001039.00
SPSY.L income_statement (annual, 2025-12-31) — Gross Profit: 37071939.00
SPSY.L income_statement (annual, 2025-12-31) — Interest Expense: 166503.00
SPSY.L income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 166503.00
SPSY.L income_statement (annual, 2025-12-31) — Interest Income: 178540.00
SPSY.L income_statement (annual, 2025-12-31) — Interest Income Non Operating: 178540.00
SPSY.L balance_sheet (annual, 2025-12-31) — Inventories Adjustments Allowances: -1234000.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Inventories Adjustments Allowances: -1234000.00
SPSY.L balance_sheet (annual, 2025-12-31) — Inventory: 8026802.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Inventory: 8026802.00
SPSY.L balance_sheet (annual, 2025-12-31) — Invested Capital: 54461844.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Invested Capital: 54461844.00
SPSY.L cash_flow (annual, 2025-12-31) — Investing Cash Flow: -1611562.00
SPSY.L balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 4483704.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 4483704.00
SPSY.L balance_sheet (annual, 2025-12-31) — Long Term Debt: 1233233.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 1233233.00
SPSY.L balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 5716937.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 5716937.00
SPSY.L cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -1365176.00
SPSY.L balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 14507191.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 14507191.00
SPSY.L balance_sheet (annual, 2025-12-31) — Minority Interest: 544014.00
SPSY.L balance_sheet (quarterly, 2025-12-31) — Minority Interest: 544014.00
SPSY.L income_statement (annual, 2025-12-31) — Minority Interests: 10704.00
SPSY.L cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -36000.00
SPSY.L income_statement (annual, 2025-12-31) — Net Income: 20055897.00
SPSY.L income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 20055897.00
SPSY.L income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 20045193.00
SPSY.L income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 20055897.00
SPSY.L income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 20055897.00
SPSY.L cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 20045193.00
SPSY.L income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 20045193.00